SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-504187
Filing Date
2016-03-15
Accepted
2016-03-15 06:06:01
Documents
3
Period of Report
2016-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d135599d8k.htm 8-K 20152
2 EX-99.1 d135599dex991.htm EX-99.1 161647
3 GRAPHIC g135599g0315121937565.jpg GRAPHIC 3800
  Complete submission text file 0001193125-16-504187.txt   188581
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 161505486
SIC: 2834 Pharmaceutical Preparations